Skip to main content
. 2016 Dec 27;8(3):5371–5381. doi: 10.18632/oncotarget.14260

Figure 3. Mean fluorescence intensity (MFI) of A. CD40 and B. CD80 of BMDCs after treatment with Gardi-PLGA, DMXAA, and their combination at various concentrations.

Figure 3